The interaction of hepatic lipid and glucose metabolism in liver diseases.
By L. Bechmann, Rebekka A. Hannivoort, G. Gerken, G. Hotamışlıgil, M. Trauner, Ali Canbay. Journal of Hepatology, 2012
918 citations recorded by the source corpus.
It is widely known that the liver is a central organ in lipogenesis, gluconeogenesis and cholesterol metabolism. However, over the last decades, a variety of pathological conditions highlighted the importance of metabolic functions within the diseased liver. As observed in Western societies, an increase in the prevalence of obesity and the metabolic syndrome promotes pathophysiological changes that cause non-alcoholic fatty liver disease (NAFLD). NAFLD increases the susceptibility of the liver to acute liver injury and may lead to cirrhosis and hepatocellular cancer. Alterations in insulin response, β-oxidation, lipid storage and transport, autophagy and an imbalance in chemokines and nuclear receptor signaling are held accountable for these changes. Furthermore, recent studies revealed a role for lipid accumulation in inflammation and ER stress in the clinical context of liver regeneration and hepatic carcinogenesis. This review focuses on novel findings related to nuclear receptor signaling - including the vitamin D receptor and the liver receptor homolog 1 - in hepatic lipid and glucose uptake, storage and metabolism in the clinical context of NAFLD, liver regeneration, and cancer.
Subfields: Epidemiology, Molecular Biology, Surgery
View Paper: https://www.semanticscholar.org/paper/f8d031f7e9d2772a68c81629dd68f6fd99f6763d
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Epidemiology
Citations in the corpus
- Molecular mechanisms of hepatic lipid accumulation in non-alcoholic fatty liver disease (2018, background): “1 3 interactions between hormones, nuclear receptors, and transcription factors, keeping hepatic lipid homeostasis under tight control [12].”